Literature DB >> 23800998

Historical use of x-rays: treatment of inner ear infections and prevention of deafness.

E J Calabrese1, G Dhawan.   

Abstract

PURPOSE: This article provides an historical assessment of the role of radiotherapy in the treatment of inner ear infections.
MATERIALS AND METHODS: The research utilized a literature-based evaluation of the use of x-rays during the first half of the 20th century on the treatment of otitis media (OM), mastoiditis, and cervical adenitis and their impact on the occurrence of deafness.
RESULTS: X-Rays were consistently found to be effective as a treatment modality at relatively low doses, in the range of 10-20% of the skin erythema dose, rapidly reducing inflammation, and accelerating the healing process. The mechanistic basis of the clinical successes, while addressed by contemporary researchers, is evaluated in the present article in light of current molecular biology advances, which indicate that clinically effective low doses of ionizing radiation act via the creation of an anti-inflammatory phenotype in highly inflamed tissue.
CONCLUSIONS: X-Ray treatment of OM, mastoiditis, and cervical adenitis was widely accepted in the first half of the 20th century by clinicians as an effective treatment when administered within an appropriate dosage range.

Entities:  

Keywords:  X-Rays; deafness; mastoiditis; otis media; radiotherapy; radium

Mesh:

Year:  2013        PMID: 23800998     DOI: 10.1177/0960327113493303

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  15 in total

1.  Radiation-hormesis phenotypes, the related mechanisms and implications for disease prevention and therapy.

Authors:  Bobby R Scott
Journal:  J Cell Commun Signal       Date:  2014-10-17       Impact factor: 5.782

2.  Commentary on fukushima and beneficial effects of low radiation.

Authors:  Jerry M Cuttler
Journal:  Dose Response       Date:  2013-05-24       Impact factor: 2.658

3.  The historical use of radiotherapy in the treatment of sinus infections.

Authors:  Edward J Calabrese; Gaurav Dhawan
Journal:  Dose Response       Date:  2013-04-11       Impact factor: 2.658

4.  Incidence of and Risk Factors for Mastoiditis after Intensity Modulated Radiotherapy in Nasopharyngeal Carcinoma.

Authors:  Ji-Jin Yao; Guan-Qun Zhou; Xiao-Li Yu; Ling-Long Tang; Lei Chen; Yan-Ping Mao; Li Lin; Lu-Lu Zhang; Jian-Yong Shao; Ying Guo; Jun Ma; Ying Sun
Journal:  PLoS One       Date:  2015-06-26       Impact factor: 3.240

5.  How radiotherapy was historically used to treat pneumonia: could it be useful today?

Authors:  Edward J Calabrese; Gaurav Dhawan
Journal:  Yale J Biol Med       Date:  2013-12-13

6.  Radiotherapy for Pertussis: An Historical Assessment.

Authors:  Edward J Calabrese; Gaurav Dhawan; Rachna Kapoor
Journal:  Dose Response       Date:  2017-05-08       Impact factor: 2.658

Review 7.  Low dose radiation therapy as a potential life saving treatment for COVID-19-induced acute respiratory distress syndrome (ARDS).

Authors:  Gaurav Dhawan; Rachna Kapoor; Rajiv Dhawan; Ravinder Singh; Bharat Monga; James Giordano; Edward J Calabrese
Journal:  Radiother Oncol       Date:  2020-05-08       Impact factor: 6.280

Review 8.  Nanoparticles for the Treatment of Inner Ear Infections.

Authors:  Dan Cristian Gheorghe; Adelina-Gabriela Niculescu; Alexandra Cătălina Bîrcă; Alexandru Mihai Grumezescu
Journal:  Nanomaterials (Basel)       Date:  2021-05-17       Impact factor: 5.076

Review 9.  Treating infections with ionizing radiation: a historical perspective and emerging techniques.

Authors:  B van Dijk; J V C Lemans; R M Hoogendoorn; E Dadachova; J M H de Klerk; H C Vogely; H Weinans; M G E H Lam; B C H van der Wal
Journal:  Antimicrob Resist Infect Control       Date:  2020-07-31       Impact factor: 4.887

Review 10.  Necrotizing Fasciitis: Low-Dose Radiotherapy as a Potential Adjunct Treatment.

Authors:  Gaurav Dhawan; Rachna Kapoor; Asha Dhamija; Ravinder Singh; Bharat Monga; Edward J Calabrese
Journal:  Dose Response       Date:  2019-08-28       Impact factor: 2.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.